News

The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...
Johnson & Johnson’s Abiomed has recalled automated controllers for its Impella heart pumps over a fault linked to three ...
Vivian Health reports AI is revolutionizing medical imaging, enhancing speed, accuracy, and patient care through advanced ...
Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...
The FDA has approved Gamifant for the treatment of adult and pediatric patients with HLH/MAS in known or suspected Still disease.
Mustang Bio Inc (NASDAQ:MBIO) stock soared over 78% following the U.S. Food and Drug Administration’s orphan drug designation for its MB-101 therapy targeting recurrent diffuse and anaplastic ...
Vita Warehouse Corp. recalled more than 40,000 bottles of Vitamin B12 supplements for possible undeclared presence of peanut.
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
The steady erosion of experienced staff is slowly compromising FDA work and low morale is pushing more workers to the exit ...
ImmunityBio, Inc. (NASDAQ:IBRX) is a clinical-stage immunotherapy company that develops next-generation therapies to treat ...
This summer, the U.S. Department of Agriculture (USDA) is finalizing new national rules for labeling and marketing lab-grown ...
Hims & Hers, the high-flying online health company that rapidly grew from a buzzy startup selling Viagra to a multibillion-dollar business, had a hard month.